- Investing Ideas
- /
- Japanese Pharmaceuticals & Biotech Profitable Climbers
Japanese Pharmaceuticals & Biotech Profitable Climbers
Results
2
1 new
2 companies
Sawai Group Holdings
Market Cap: JP¥272.4b
Together with subsidiaries, engages in the research and development, manufacture, and marketing of generic pharmaceuticals.
New
4887
JP¥2,359.00
7D
-2.0%
1Y
9.7%
Kidswell Bio
Market Cap: JP¥10.1b
Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.
4584
JP¥203.00
7D
-1.0%
1Y
84.5%